The Corner Series

Hosted by McGuireWoods

Business News EducationInterviews guests

Website RSS feed LinkedIn

Episodes

129

Latest episode

Oct 2026

Language

About the show

“The Corner Series” is a multiperspective podcast series by McGuireWoods featuring commentaries from lawyers, bankers and a number of specialists about the developments and issues dominating today’s middle-market private equity. Tune in with McGuireWoods partner, Geoff Cockrell as he and specialists share real-world insight to help enhance your knowledge. McGuireWoods is a full-service firm providing legal and public affairs solutions to corporate, individual, and nonprofit clients worldwide for more than 200 years collectively. Our commitment to excellence in everything we do gives our clients a competitive edge in everything they do. Our law firm, over its 186-year history, has earned the loyalty of our many long-standing clients with a deep understanding of their businesses, and broad skills in corporate transactions, high-stakes disputes, and complex regulatory and compliance matters. To learn more about our discussions, please email host Geoff Cockrell at gcockrell@mcguirewoods.com or visit our website at mcguirewoods.com. This series was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this series, you acknowledge that McGuireWoods makes no warranty, guarantee or representation as to the accuracy or sufficiency of the information featured in this installment. The views, information or opinions expressed are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This series should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

Listen to episodes

60 recent

October 14, 202627 min

Episode 141: Defusing Post-Closing Deal Disputes, With Jeff Golimowski

When private equity clients ask Jeff Golimowski how to avoid getting sued after a deal, his answer is simple: You can’t prevent every possible lawsuit. The real question is how to mitigate the risk. A litigator and McGuireWoods partner, Jeff represents buyers and sellers in post-closing disputes, which are rising as longer hold periods coincide with earnout and working capital conflicts. In this conversation with McGuireWoods partner and host Geoff Cockrell , Jeff explains how two statements in a reliance clause can prevent disputes, and why GAAP-based definitions beat hyper-technical ones when a case reaches a judge or arbitrator. Tune in for practical advice on limiting post-closing fights and knowing when one is worth litigating. Connect and Learn More ☑️ Jeff Golimowski | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

September 29, 202619 min

Episode 140: The Future of SaaS in Healthcare, With Noah Lewis

SaaS is dead in the age of AI, say many in healthcare software. Not so fast, says Noah Lewis , managing partner at Ardan Equity , a sector specialist at the intersection of healthcare, life sciences and technology. Arguing that the “SaaSpocalypse” is overblown, he joins McGuireWoods partner and host Geoff Cockrell to discuss AI’s impact on health tech. Noah explains how he screens for “melting ice cube risk” and sees commercialization, not technology cost, as the real competitive moat. He also unpacks why healthcare’s aging $400 billion tech stack makes the present a golden age for health tech, and contends the market is shifting from inflationary to deflationary business models. It leads to one question: Who wins and loses as AI transforms healthcare? Connect and Learn More ☑️ Noah Lewis | LinkedIn ☑️ Ardan Equity | LinkedIn | X ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action. PITCHBOOK TOP 5 RANKING IS FROM THE PITCHBOOK Q2 2025 HEALTHTECH VC TRENDS REPORT AS OF JUNE 30, 2025. THIS RANKING COVERS THE PERIOD BETWEEN 2019 – Q2 2025. ARDAN WAS RANKED #2 IN THE TOP PE INVESTORS IN HEALTHTECH COMPANIES SINCE 2019 BY DEAL COUNT AS OF JUNE 30, 2025, PER PITCHBOOK INFORMATION. WE DID NOT PROVIDE PITCHBOOK COMPENSATION FOR THIS RANKING.

September 16, 202621 min

Episode 139: Investing in Precision Health, With Chris Dorn

Demand for concierge and functional medicine is surging, fueled by the GLP-1 boom and by healthcare costs increasingly shifting onto consumers. Fifth Third Securities managing director Chris Dorn describes this space, also known as “precision health,” as a consultative healthcare model where patients get more time with their physician and access to treatments standard primary care won't provide. In this conversation with McGuireWoods partner and host Geoff Cockrell , Chris digs into the details investors weigh: how much GLP-1 exposure sinks a deal's appeal, and who actually buys these businesses once they reach real scale. Tune in for where the opportunity — and the traps — lie in one of healthcare's fastest-emerging markets. Connect and Learn More ☑️ Chris Dorn | LinkedIn ☑️ Fifth Third Securities | LinkedIn | Facebook | Instagram ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

August 26, 202623 min

Episode 138: Prescribed Pediatric Care at Scale, With Jeff Soffen

Three million children in the U.S. could benefit from Prescribed Pediatric Extended Care (PPEC), but most families don't know it exists. Jeffrey Soffen, CEO of Spark Pediatrics , the largest PPEC provider in the country, joins McGuireWoods partner Tim Fry on The Corner Series. Jeff explains how today's standard of care leaves 40 to 60 percent of skilled nursing hours unfulfilled, forcing medically complex children to remain hospitalized for upward of 500 days. Spark's model places children in community-based centers for skilled nursing, therapies and peer socialization. Tune in for Jeff's perspective on state-by-state legislative expansion, health system partnership and why you can do well by doing good in Medicaid. Connect and Learn More ☑️ Jeffrey Soffen | LinkedIn ☑️ Spark Pediatrics | LinkedIn | Facebook | Instagram ☑️ Tim Fry | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

August 12, 202621 min

Episode 137: The Compliance Playbook Behind Today’s Booming Wellness Clinics, With John Bradburn and Chris Seitz

As private equity investment in healthcare compliance and wellness accelerates, oversight infrastructure helps non-physician providers to scale. Dr. Christopher Seitz , CEO and CMO of GuardianMD , joins John Bradburn , a partner at Elements Health Investors , to discuss mid-level providers reshaping access to care. Chris details Guardian’s role in helping clinicians navigate licensing rules. Guardian launched five years ago to build compliance infrastructure for telemedicine and outpatient providers. John explains Elements’ thesis of backing companies that improve outcomes at lower cost. McGuireWoods partner and host Geoff Cockrell steers the conversation toward AI’s growing role in medical oversight, calling it a massive opportunity. John closes by addressing misconceptions about private equity in healthcare and outlining Guardian’s growth strategy. Connect and Learn More ☑️ Christopher Seitz | LinkedIn ☑️ Gaurdian Medical Direction | LinkedIn | Facebook | Instagram | YouTube ☑️ John Bradburn | LinkedIn ☑️ Element Health Investors | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

July 29, 202619 min

Episode 136: Med Spa Growth and Capital Strategy, With Amanda Blank

Amanda Blank , CEO of Founders Beauty Group , joins McGuireWoods partner and host Geoff Cockrell to discuss the growth of her strategic med spa platform, built on a hub-and-spoke model across four geographies through the acquisition of established, doctor-owned, cash-pay practices. Amanda shares how she evaluated different capital sources during the company's growth, including her decision to partner with high-net-worth family offices rather than private equity investors at that stage of the business, and discusses the factors that informed that approach. She also explores why specialized industry knowledge matters for investors in the med spa sector, why GLP-1s are unlikely to serve as an anchor service, where durable competitive advantages exist in a relatively low-barrier market and how her experience leading a woman-owned platform has shaped the company's growth. Connect and Learn More ☑️ Amanda Blank | LinkedIn ☑️ Founders Beauty Group | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

July 15, 202620 min

Episode 135: The Thaw Has Arrived in Provider Services M&A, With J. Kyle Brown

The provider services M&A market is probably approaching 50% of peak deal volume — well below historical norms — yet J. Kyle Brown sees real momentum building. Kyle is managing director and lead of the provider services group at Brown Gibbons Lang & Company . In this conversation with McGuireWoods partner and host Geoff Cockrell , Kyle unpacks how, after holding over a hundred private equity provider services assets for six years, demand finally feels different – the first real shift since early 2023. They examine the evolution from TopCo MSO equity to near-term incentive structures and discuss which subsectors — ASCs, infusion, ENT, and interventional pain — are drawing the most investor attention. Connect and Learn More ☑️ J. Kyle Brown | LinkedIn ☑️ Brown Gibbons Lang & Company | LinkedIn | X ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

July 8, 202615 min

Episode 134: Healthcare Compliance as a Deal Asset, With Wiks Moffat

Compliance is no longer a fire drill to be ignored. Wiks Moffat , founder and CEO of Calyx Compliance with 30 years of healthcare compliance experience, says the enforcement environment has accelerated, with AI now helping regulators spot outliers. In conversation with McGuireWoods partner and host Geoff Cockrell , Wiks explains how most companies still aren’t doing enough self-assessment, how billing and coding is almost always where scrutiny begins, and how compliance can generate a clear ROI by surfacing missed revenue opportunities post-acquisition. Tune in for guidance on compliance staffing thresholds and why sellers should start due diligence 18 months ahead. Connect and Learn More ☑️ Wiks Moffat ☑️ Calyx Compliance | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

June 17, 202619 min

Episode 133: One Portal for Every Perinatal Journey, With Ian Gardner

Ian Gardner and his wife struggled to assemble a holistic care team during her pregnancy. At the end of their journey, they had a son — and a solution they called MilkWise, a one-stop portal where mothers can access experts and specialists so they can focus on their infants, not on searching through their various healthcare packages. “We saw platforms and companies that provided specific components, say, for postpartum depression, pelvic floor rehab or lactation, but no single destination where a mom could go,” Ian explains to McGuireWoods partner and host Geoff Cockrell . Tune in as Ian describes how MilkWise uses lactation consulting as its market wedge, why payers — not providers — are the biggest operational challenge, and the three pillars MikeWise is built on: products, providers and payers. Connect and Learn More ☑️ Ian Gardner | LinkedIn ☑️ MilkWise | Linkedin | Instagram ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.

June 3, 202622 min

Episode 132: Navigating Nuances of Life Sciences Post-Closing, With Amy Cassalia

McGuireWoods partner and host Geoff Cockrell invites colleague Amy Cassalia — whose practice is heavily weighted on life sciences transactions — to share insights about the post-closing period of these complex deals. The wide-ranging conversation covers the dynamics of “contingent consideration,” investor risk and buyers’ leverage. Amy explains why she sees high-level use of contingent payments in life sciences deals and why the term “commercially reasonable” often becomes critical when a deal spirals into litigation. Stay tuned as she unpacks leading trends. Top among them? The increasing use of earn-outs. Connect and Learn More ☑️ Amy Cassalia | LinkedIn ☑️ Geoff Cockrell | LinkedIn ☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X ☑️ Subscribe Apple Podcasts | Spotify | Amazon Music This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.